Roy is a member of the Boards of Directors of Thermedical, VytronUS, EPIX Therapeutics, and BioSig Technologies, medical device start-ups developing technologies for treating atrial fibrillation, a cardiac arrhythmia.
He has also served on the boards of Volcano Corporation, a company that develops intravascular ultrasound that aid in the diagnosis and treatment of vascular and structural heart disease, TomoTherapy Incorporated, an advanced radiation therapy company that markets systems for the treatment of a wide range of cancer types, and Coherex, an atrial appendage closure device company. Prior to his retirement, Roy was the Worldwide President of Biosense Webster, a Johnson & Johnson Company, from March, 2004 until his retirement in September, 2008. Biosense Webster is the market and technology leader in the field of electrophysiology, a subspecialty of cardiology dedicated to the diagnosis and treatment of heart rhythm disorders.
